Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Adrenal Gland Neoplasms | 23 | 2024 | 733 | 4.820 |
Why?
|
Adrenal Gland Diseases | 10 | 2020 | 141 | 3.630 |
Why?
|
Tomography, X-Ray Computed | 87 | 2024 | 20509 | 3.040 |
Why?
|
Incidental Findings | 14 | 2021 | 698 | 2.420 |
Why?
|
Catheter Ablation | 25 | 2015 | 2758 | 2.000 |
Why?
|
Radiology | 16 | 2022 | 2102 | 1.630 |
Why?
|
Diagnostic Imaging | 14 | 2021 | 3527 | 1.620 |
Why?
|
Radiation Protection | 4 | 2018 | 425 | 1.590 |
Why?
|
Radiography, Interventional | 10 | 2016 | 1114 | 1.220 |
Why?
|
Radiography, Abdominal | 8 | 2016 | 532 | 1.030 |
Why?
|
Kidney Neoplasms | 14 | 2018 | 4312 | 1.010 |
Why?
|
Radiation Dosage | 8 | 2016 | 1958 | 1.010 |
Why?
|
Adenoma | 7 | 2023 | 2148 | 0.970 |
Why?
|
Contrast Media | 30 | 2023 | 5305 | 0.900 |
Why?
|
Abdominal Pain | 6 | 2012 | 1063 | 0.890 |
Why?
|
Surgery, Computer-Assisted | 6 | 2013 | 1008 | 0.890 |
Why?
|
Myelolipoma | 1 | 2023 | 14 | 0.870 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 6 | 2015 | 1215 | 0.800 |
Why?
|
Adrenocortical Adenoma | 4 | 2023 | 46 | 0.740 |
Why?
|
Societies, Medical | 6 | 2021 | 3905 | 0.730 |
Why?
|
Urography | 2 | 2012 | 312 | 0.730 |
Why?
|
Body Burden | 2 | 2012 | 158 | 0.720 |
Why?
|
Hematuria | 2 | 2012 | 233 | 0.720 |
Why?
|
Ablation Techniques | 4 | 2018 | 248 | 0.710 |
Why?
|
Radiometry | 3 | 2015 | 813 | 0.700 |
Why?
|
Advisory Committees | 3 | 2018 | 788 | 0.640 |
Why?
|
Pheochromocytoma | 3 | 2014 | 328 | 0.630 |
Why?
|
Artifacts | 4 | 2013 | 1898 | 0.600 |
Why?
|
Sensitivity and Specificity | 28 | 2024 | 14660 | 0.550 |
Why?
|
Colonography, Computed Tomographic | 2 | 2015 | 169 | 0.540 |
Why?
|
Appendicitis | 3 | 2013 | 674 | 0.490 |
Why?
|
Carcinoma, Renal Cell | 7 | 2016 | 3218 | 0.470 |
Why?
|
Diagnosis, Differential | 22 | 2023 | 12965 | 0.460 |
Why?
|
Body Size | 2 | 2015 | 462 | 0.450 |
Why?
|
Adrenocortical Carcinoma | 1 | 2014 | 88 | 0.440 |
Why?
|
Lipoma | 2 | 2009 | 292 | 0.440 |
Why?
|
Humans | 168 | 2024 | 760621 | 0.430 |
Why?
|
Adrenal Glands | 4 | 2022 | 554 | 0.420 |
Why?
|
Pregnancy Complications | 4 | 2010 | 2942 | 0.410 |
Why?
|
Iodine | 2 | 2016 | 286 | 0.410 |
Why?
|
Sigmoid Diseases | 1 | 2012 | 59 | 0.410 |
Why?
|
Liver Neoplasms | 14 | 2013 | 4319 | 0.410 |
Why?
|
Body Water | 1 | 2013 | 341 | 0.400 |
Why?
|
Cryosurgery | 2 | 2008 | 475 | 0.390 |
Why?
|
Algorithms | 13 | 2022 | 13981 | 0.380 |
Why?
|
Foreign Bodies | 2 | 2012 | 397 | 0.370 |
Why?
|
Urinary Calculi | 1 | 2011 | 91 | 0.370 |
Why?
|
Barium Sulfate | 1 | 2011 | 180 | 0.370 |
Why?
|
Efficiency, Organizational | 2 | 2020 | 697 | 0.370 |
Why?
|
Models, Organizational | 1 | 2014 | 545 | 0.370 |
Why?
|
Aged, 80 and over | 42 | 2018 | 58995 | 0.350 |
Why?
|
Middle Aged | 76 | 2024 | 220352 | 0.350 |
Why?
|
Burns, Electric | 1 | 2010 | 40 | 0.350 |
Why?
|
Radiography | 9 | 2020 | 6965 | 0.340 |
Why?
|
Ultrasonography, Interventional | 4 | 2016 | 1502 | 0.340 |
Why?
|
Magnetic Resonance Imaging | 28 | 2023 | 36290 | 0.340 |
Why?
|
Workload | 2 | 2020 | 847 | 0.330 |
Why?
|
Aged | 69 | 2018 | 169152 | 0.330 |
Why?
|
Whole-Body Counting | 1 | 2009 | 36 | 0.330 |
Why?
|
Flank Pain | 1 | 2009 | 43 | 0.330 |
Why?
|
Workflow | 1 | 2014 | 852 | 0.330 |
Why?
|
Lung Neoplasms | 14 | 2011 | 13262 | 0.330 |
Why?
|
Adult | 75 | 2018 | 219994 | 0.330 |
Why?
|
Adrenalectomy | 1 | 2011 | 348 | 0.330 |
Why?
|
Retrospective Studies | 41 | 2024 | 80372 | 0.320 |
Why?
|
Pulmonary Embolism | 5 | 2011 | 2543 | 0.320 |
Why?
|
Education, Medical, Graduate | 2 | 2018 | 2363 | 0.320 |
Why?
|
Liver Diseases | 6 | 2009 | 1302 | 0.310 |
Why?
|
Hernia | 1 | 2008 | 68 | 0.310 |
Why?
|
Gases | 3 | 2003 | 203 | 0.310 |
Why?
|
Microwaves | 3 | 2008 | 185 | 0.310 |
Why?
|
Radiation Injuries | 2 | 2015 | 1183 | 0.310 |
Why?
|
Speech Recognition Software | 1 | 2008 | 74 | 0.310 |
Why?
|
Leadership | 1 | 2018 | 1371 | 0.310 |
Why?
|
Ultrasonography | 6 | 2014 | 5961 | 0.300 |
Why?
|
Female | 96 | 2024 | 391270 | 0.300 |
Why?
|
Mesentery | 1 | 2008 | 202 | 0.300 |
Why?
|
Biopsy | 9 | 2018 | 6771 | 0.300 |
Why?
|
Male | 88 | 2024 | 359744 | 0.290 |
Why?
|
Radiographic Image Enhancement | 2 | 2011 | 875 | 0.290 |
Why?
|
Metals | 1 | 2012 | 736 | 0.290 |
Why?
|
Fecal Impaction | 1 | 2007 | 32 | 0.290 |
Why?
|
Hepatic Duct, Common | 2 | 1999 | 48 | 0.280 |
Why?
|
Rhode Island | 6 | 2012 | 349 | 0.280 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2009 | 418 | 0.280 |
Why?
|
Stomach Ulcer | 1 | 2007 | 123 | 0.280 |
Why?
|
Bile Duct Neoplasms | 3 | 1999 | 602 | 0.280 |
Why?
|
Tomography, Spiral Computed | 3 | 2009 | 273 | 0.270 |
Why?
|
Observer Variation | 6 | 2013 | 2601 | 0.260 |
Why?
|
Decision Making | 2 | 2018 | 3925 | 0.260 |
Why?
|
Radiology Information Systems | 2 | 2008 | 528 | 0.250 |
Why?
|
Therapy, Computer-Assisted | 1 | 2007 | 267 | 0.250 |
Why?
|
Bone Neoplasms | 4 | 2005 | 2532 | 0.250 |
Why?
|
Electrocoagulation | 1 | 2005 | 152 | 0.250 |
Why?
|
Cerebral Angiography | 4 | 2008 | 1274 | 0.250 |
Why?
|
Equipment Failure | 1 | 2007 | 577 | 0.250 |
Why?
|
Equipment Failure Analysis | 1 | 2007 | 848 | 0.240 |
Why?
|
Reproducibility of Results | 12 | 2017 | 20080 | 0.240 |
Why?
|
Image Processing, Computer-Assisted | 5 | 2016 | 8950 | 0.230 |
Why?
|
Multi-Institutional Systems | 1 | 2003 | 43 | 0.230 |
Why?
|
Image Enhancement | 5 | 2009 | 2881 | 0.230 |
Why?
|
User-Computer Interface | 2 | 2018 | 1403 | 0.220 |
Why?
|
Cholestasis | 2 | 1999 | 377 | 0.220 |
Why?
|
Iohexol | 6 | 2011 | 204 | 0.220 |
Why?
|
Developing Countries | 2 | 2013 | 2868 | 0.220 |
Why?
|
Adrenal Cortex Neoplasms | 2 | 2003 | 161 | 0.220 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 5 | 2010 | 5251 | 0.220 |
Why?
|
Medical Records | 1 | 2008 | 1407 | 0.210 |
Why?
|
Brain Diseases | 2 | 2004 | 1540 | 0.210 |
Why?
|
Angiomyolipoma | 2 | 2009 | 184 | 0.210 |
Why?
|
Ultrasonography, Mammary | 1 | 2005 | 239 | 0.210 |
Why?
|
Peritoneal Neoplasms | 1 | 2009 | 707 | 0.210 |
Why?
|
Angiography | 2 | 2008 | 1605 | 0.210 |
Why?
|
Periodicals as Topic | 1 | 2013 | 1469 | 0.200 |
Why?
|
Liver | 10 | 2009 | 7509 | 0.200 |
Why?
|
Risk Management | 2 | 2016 | 558 | 0.200 |
Why?
|
Embolization, Therapeutic | 1 | 2012 | 1413 | 0.200 |
Why?
|
Computer Systems | 1 | 2003 | 470 | 0.200 |
Why?
|
Intestines | 1 | 2011 | 1907 | 0.200 |
Why?
|
Hemorrhage | 2 | 2016 | 3600 | 0.200 |
Why?
|
Digestive System Diseases | 2 | 2003 | 151 | 0.200 |
Why?
|
Databases as Topic | 1 | 2003 | 474 | 0.190 |
Why?
|
Pacemaker, Artificial | 1 | 2007 | 815 | 0.190 |
Why?
|
Adenoma, Oxyphilic | 1 | 2003 | 148 | 0.190 |
Why?
|
Portal Vein | 3 | 2003 | 429 | 0.190 |
Why?
|
Breast Diseases | 1 | 2005 | 443 | 0.190 |
Why?
|
Pancreaticojejunostomy | 1 | 2000 | 26 | 0.190 |
Why?
|
Jejunal Neoplasms | 1 | 2000 | 19 | 0.190 |
Why?
|
Cecal Diseases | 1 | 2000 | 49 | 0.180 |
Why?
|
Teaching Materials | 1 | 2001 | 84 | 0.180 |
Why?
|
Internship and Residency | 2 | 2018 | 5870 | 0.180 |
Why?
|
Public Health | 2 | 2013 | 2653 | 0.180 |
Why?
|
Jejunal Diseases | 1 | 2000 | 46 | 0.180 |
Why?
|
Lymphoma, B-Cell | 1 | 2007 | 935 | 0.180 |
Why?
|
Pyelonephritis | 1 | 2000 | 75 | 0.180 |
Why?
|
Stents | 3 | 1999 | 3314 | 0.180 |
Why?
|
Gastric Bypass | 1 | 2008 | 829 | 0.170 |
Why?
|
Congresses as Topic | 3 | 2014 | 805 | 0.170 |
Why?
|
Abdomen | 2 | 2017 | 1130 | 0.170 |
Why?
|
Intussusception | 1 | 2000 | 115 | 0.170 |
Why?
|
Terminology as Topic | 2 | 2018 | 1535 | 0.170 |
Why?
|
Treatment Outcome | 19 | 2018 | 65017 | 0.170 |
Why?
|
Pancreatic Ducts | 2 | 2000 | 329 | 0.170 |
Why?
|
Enteritis | 1 | 2000 | 162 | 0.170 |
Why?
|
Colorectal Neoplasms | 2 | 2010 | 6853 | 0.160 |
Why?
|
Neurocysticercosis | 1 | 2000 | 91 | 0.160 |
Why?
|
Spine | 3 | 2000 | 1111 | 0.160 |
Why?
|
Biopsy, Needle | 6 | 2009 | 1630 | 0.160 |
Why?
|
Pyridoxal Phosphate | 2 | 1998 | 124 | 0.160 |
Why?
|
Equipment Design | 4 | 2015 | 3520 | 0.160 |
Why?
|
Crohn Disease | 1 | 2011 | 2275 | 0.160 |
Why?
|
Computers | 1 | 2001 | 595 | 0.150 |
Why?
|
Edetic Acid | 2 | 1998 | 282 | 0.150 |
Why?
|
Forecasting | 2 | 2018 | 2932 | 0.150 |
Why?
|
Radiology Department, Hospital | 1 | 2002 | 405 | 0.150 |
Why?
|
Genital Diseases, Female | 1 | 1999 | 191 | 0.150 |
Why?
|
Teratoma | 1 | 2001 | 403 | 0.150 |
Why?
|
Palliative Care | 4 | 2007 | 3607 | 0.150 |
Why?
|
Emphysema | 1 | 2000 | 240 | 0.150 |
Why?
|
Cushing Syndrome | 2 | 1989 | 241 | 0.140 |
Why?
|
Oxides | 2 | 1996 | 401 | 0.140 |
Why?
|
Stomach Neoplasms | 1 | 2007 | 1423 | 0.140 |
Why?
|
Radioisotope Teletherapy | 1 | 1996 | 15 | 0.140 |
Why?
|
Iridium Radioisotopes | 1 | 1996 | 26 | 0.140 |
Why?
|
Electronic Mail | 1 | 2018 | 213 | 0.140 |
Why?
|
Cobalt Radioisotopes | 1 | 1996 | 75 | 0.140 |
Why?
|
Education, Distance | 1 | 2020 | 258 | 0.140 |
Why?
|
Environmental Exposure | 1 | 2011 | 4412 | 0.130 |
Why?
|
Nephrectomy | 2 | 2012 | 1016 | 0.130 |
Why?
|
Unnecessary Procedures | 2 | 2018 | 413 | 0.130 |
Why?
|
Risk Assessment | 7 | 2018 | 24123 | 0.130 |
Why?
|
Brachytherapy | 2 | 2010 | 1238 | 0.130 |
Why?
|
Education, Medical | 2 | 2013 | 1727 | 0.130 |
Why?
|
Diatrizoate Meglumine | 1 | 2015 | 79 | 0.130 |
Why?
|
Uncertainty | 2 | 2018 | 754 | 0.130 |
Why?
|
Blood Vessel Prosthesis | 1 | 2000 | 956 | 0.130 |
Why?
|
Patient Selection | 3 | 2013 | 4283 | 0.120 |
Why?
|
Catheterization | 1 | 2000 | 1432 | 0.120 |
Why?
|
Pregnancy | 6 | 2010 | 29749 | 0.120 |
Why?
|
Positron-Emission Tomography | 4 | 2014 | 6465 | 0.120 |
Why?
|
Predictive Value of Tests | 7 | 2024 | 15289 | 0.120 |
Why?
|
Kidney Calculi | 1 | 1999 | 468 | 0.120 |
Why?
|
Drainage | 3 | 2016 | 1161 | 0.120 |
Why?
|
Equipment Safety | 1 | 2015 | 253 | 0.120 |
Why?
|
Pancreatitis | 2 | 2002 | 1100 | 0.120 |
Why?
|
Software | 2 | 2015 | 4419 | 0.120 |
Why?
|
Gastrointestinal Diseases | 1 | 2022 | 1190 | 0.120 |
Why?
|
Cerebrovascular Circulation | 1 | 2004 | 2733 | 0.110 |
Why?
|
Deglutition | 2 | 2012 | 208 | 0.110 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 2015 | 881 | 0.110 |
Why?
|
Scoliosis | 1 | 2000 | 735 | 0.110 |
Why?
|
Cooking and Eating Utensils | 1 | 2012 | 3 | 0.110 |
Why?
|
Pulmonary Artery | 3 | 2011 | 1921 | 0.110 |
Why?
|
Teleradiology | 1 | 2013 | 53 | 0.110 |
Why?
|
Fluoroscopy | 3 | 2012 | 948 | 0.100 |
Why?
|
Blood Coagulation Disorders | 1 | 2016 | 349 | 0.100 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3085 | 0.100 |
Why?
|
Adolescent | 19 | 2012 | 87810 | 0.100 |
Why?
|
Household Articles | 1 | 2012 | 21 | 0.100 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3205 | 0.100 |
Why?
|
Cadaver | 1 | 2016 | 1345 | 0.100 |
Why?
|
Bile Ducts, Intrahepatic | 1 | 1993 | 296 | 0.100 |
Why?
|
Journal Impact Factor | 1 | 2013 | 156 | 0.100 |
Why?
|
United States | 10 | 2021 | 72461 | 0.100 |
Why?
|
Lipids | 2 | 2023 | 3336 | 0.100 |
Why?
|
Pancreas | 2 | 1998 | 1677 | 0.100 |
Why?
|
Intestinal Obstruction | 1 | 1995 | 434 | 0.100 |
Why?
|
Osteolysis | 1 | 1993 | 274 | 0.100 |
Why?
|
Child | 11 | 2018 | 79806 | 0.100 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2015 | 547 | 0.100 |
Why?
|
Follow-Up Studies | 8 | 2015 | 39261 | 0.100 |
Why?
|
Minerals | 3 | 1989 | 283 | 0.100 |
Why?
|
Career Choice | 1 | 2018 | 754 | 0.100 |
Why?
|
Quality Assurance, Health Care | 2 | 2018 | 2176 | 0.100 |
Why?
|
Antidiarrheals | 1 | 2011 | 46 | 0.090 |
Why?
|
Cost Savings | 1 | 2016 | 920 | 0.090 |
Why?
|
Continuity of Patient Care | 1 | 2018 | 1066 | 0.090 |
Why?
|
Pelvis | 1 | 1995 | 743 | 0.090 |
Why?
|
Choice Behavior | 1 | 2017 | 821 | 0.090 |
Why?
|
Triiodobenzoic Acids | 1 | 2011 | 123 | 0.090 |
Why?
|
Point-of-Care Systems | 1 | 1999 | 1204 | 0.090 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2000 | 1223 | 0.090 |
Why?
|
International Agencies | 1 | 2011 | 244 | 0.090 |
Why?
|
Organ Specificity | 1 | 2015 | 1955 | 0.090 |
Why?
|
Wheelchairs | 2 | 1981 | 78 | 0.090 |
Why?
|
Capacity Building | 1 | 2013 | 257 | 0.090 |
Why?
|
Iopamidol | 1 | 2011 | 186 | 0.090 |
Why?
|
Endoscopy | 1 | 2000 | 1838 | 0.090 |
Why?
|
Iron | 2 | 1996 | 1786 | 0.090 |
Why?
|
Electromagnetic Phenomena | 1 | 2011 | 161 | 0.090 |
Why?
|
Artificial Intelligence | 1 | 2024 | 2557 | 0.090 |
Why?
|
Chondroblastoma | 1 | 1990 | 48 | 0.090 |
Why?
|
Radiotherapy Dosage | 4 | 2010 | 2897 | 0.090 |
Why?
|
Anorexia Nervosa | 2 | 1989 | 1361 | 0.080 |
Why?
|
Intestine, Small | 1 | 1995 | 1207 | 0.080 |
Why?
|
Work Simplification | 1 | 2008 | 8 | 0.080 |
Why?
|
Parathyroid Neoplasms | 1 | 2011 | 241 | 0.080 |
Why?
|
Meglumine | 2 | 2000 | 145 | 0.080 |
Why?
|
Eosinophilic Granuloma | 1 | 1989 | 27 | 0.080 |
Why?
|
Feces | 1 | 1995 | 1455 | 0.080 |
Why?
|
Cholangiocarcinoma | 2 | 1995 | 550 | 0.080 |
Why?
|
Emergency Service, Hospital | 6 | 2012 | 7818 | 0.080 |
Why?
|
Benchmarking | 1 | 2015 | 1044 | 0.080 |
Why?
|
Survival Rate | 6 | 2008 | 12808 | 0.080 |
Why?
|
Magnetic Resonance Angiography | 1 | 1996 | 1431 | 0.080 |
Why?
|
Quality Improvement | 3 | 2018 | 3836 | 0.080 |
Why?
|
Equipment and Supplies | 2 | 2002 | 275 | 0.080 |
Why?
|
Hyperparathyroidism, Primary | 1 | 2011 | 161 | 0.080 |
Why?
|
Liver Abscess, Pyogenic | 1 | 2008 | 7 | 0.080 |
Why?
|
Thoracoscopy | 1 | 2009 | 176 | 0.080 |
Why?
|
Ribs | 1 | 1990 | 252 | 0.080 |
Why?
|
Diffusion of Innovation | 1 | 2013 | 730 | 0.080 |
Why?
|
Maternal-Fetal Exchange | 1 | 2010 | 463 | 0.070 |
Why?
|
Private Practice | 1 | 2008 | 152 | 0.070 |
Why?
|
Chemoembolization, Therapeutic | 1 | 2008 | 127 | 0.070 |
Why?
|
Relative Biological Effectiveness | 1 | 2009 | 312 | 0.070 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2016 | 9276 | 0.070 |
Why?
|
Risk Factors | 7 | 2018 | 74359 | 0.070 |
Why?
|
Hip Prosthesis | 1 | 1993 | 920 | 0.070 |
Why?
|
Iodized Oil | 1 | 2006 | 10 | 0.070 |
Why?
|
Tomography, Emission-Computed | 3 | 2010 | 1121 | 0.070 |
Why?
|
Bone Diseases, Metabolic | 1 | 1991 | 409 | 0.070 |
Why?
|
Cohort Studies | 6 | 2015 | 41335 | 0.070 |
Why?
|
Time | 1 | 2008 | 545 | 0.070 |
Why?
|
Cryotherapy | 1 | 2007 | 161 | 0.070 |
Why?
|
Uterine Neoplasms | 1 | 1995 | 1439 | 0.070 |
Why?
|
Body Weight | 2 | 2016 | 4611 | 0.070 |
Why?
|
Laryngoscopy | 1 | 2012 | 706 | 0.070 |
Why?
|
Wrist Injuries | 1 | 1988 | 214 | 0.070 |
Why?
|
Organometallic Compounds | 2 | 2000 | 662 | 0.060 |
Why?
|
Angiography, Digital Subtraction | 2 | 2003 | 334 | 0.060 |
Why?
|
Hemangioma | 4 | 2000 | 728 | 0.060 |
Why?
|
Health Services Needs and Demand | 1 | 2013 | 1399 | 0.060 |
Why?
|
Thoracic Neoplasms | 1 | 2007 | 266 | 0.060 |
Why?
|
Bone and Bones | 4 | 1994 | 2560 | 0.060 |
Why?
|
Young Adult | 5 | 2012 | 58741 | 0.060 |
Why?
|
Ovarian Neoplasms | 2 | 2005 | 4878 | 0.060 |
Why?
|
Single-Blind Method | 1 | 2008 | 1578 | 0.060 |
Why?
|
Job Satisfaction | 1 | 2008 | 539 | 0.060 |
Why?
|
Phantoms, Imaging | 1 | 2013 | 2512 | 0.060 |
Why?
|
Communication | 1 | 2018 | 3849 | 0.060 |
Why?
|
Endoscopy, Digestive System | 1 | 2007 | 351 | 0.060 |
Why?
|
Ultrasonography, Prenatal | 2 | 2010 | 1745 | 0.060 |
Why?
|
Data Collection | 1 | 2013 | 3315 | 0.060 |
Why?
|
Adnexal Diseases | 1 | 2005 | 106 | 0.060 |
Why?
|
Cancer Care Facilities | 1 | 2007 | 424 | 0.060 |
Why?
|
Neoplasms | 4 | 2012 | 22072 | 0.060 |
Why?
|
Intracranial Aneurysm | 2 | 2003 | 1276 | 0.060 |
Why?
|
Hyperthermia, Induced | 1 | 2007 | 417 | 0.060 |
Why?
|
Appendectomy | 1 | 2007 | 431 | 0.060 |
Why?
|
Patient Care Team | 1 | 2014 | 2511 | 0.050 |
Why?
|
Pandemics | 2 | 2020 | 8624 | 0.050 |
Why?
|
Guideline Adherence | 1 | 2013 | 2283 | 0.050 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2016 | 3201 | 0.050 |
Why?
|
Incidence | 3 | 2011 | 21392 | 0.050 |
Why?
|
Subarachnoid Hemorrhage | 2 | 2008 | 1032 | 0.050 |
Why?
|
Pregnancy Complications, Neoplastic | 1 | 2005 | 255 | 0.050 |
Why?
|
Ovariectomy | 1 | 2005 | 611 | 0.050 |
Why?
|
Radius Fractures | 1 | 1988 | 513 | 0.050 |
Why?
|
Practice Guidelines as Topic | 1 | 2020 | 7475 | 0.050 |
Why?
|
Radiotherapy, Conformal | 1 | 2006 | 549 | 0.050 |
Why?
|
Case-Control Studies | 2 | 2012 | 22053 | 0.050 |
Why?
|
Bone Marrow | 3 | 1989 | 2912 | 0.050 |
Why?
|
Femur | 1 | 1989 | 1302 | 0.050 |
Why?
|
Kidney | 2 | 2015 | 7064 | 0.050 |
Why?
|
Abdomen, Acute | 1 | 2002 | 122 | 0.050 |
Why?
|
Time Factors | 5 | 2018 | 40165 | 0.050 |
Why?
|
Fluorodeoxyglucose F18 | 3 | 2007 | 2007 | 0.050 |
Why?
|
Prevalence | 2 | 2009 | 15687 | 0.050 |
Why?
|
Duodenal Diseases | 1 | 2001 | 99 | 0.050 |
Why?
|
Reoperation | 1 | 2011 | 4291 | 0.050 |
Why?
|
Neoplasm Staging | 3 | 2016 | 11152 | 0.050 |
Why?
|
Combined Modality Therapy | 3 | 2010 | 8552 | 0.050 |
Why?
|
Muscles | 2 | 1996 | 1581 | 0.040 |
Why?
|
Data Display | 1 | 2001 | 174 | 0.040 |
Why?
|
Anticoagulants | 1 | 2016 | 4897 | 0.040 |
Why?
|
Adipose Tissue | 2 | 1989 | 3301 | 0.040 |
Why?
|
Gadolinium | 3 | 2000 | 959 | 0.040 |
Why?
|
Guatemala | 1 | 2000 | 159 | 0.040 |
Why?
|
Mass Screening | 2 | 2024 | 5423 | 0.040 |
Why?
|
Preoperative Care | 1 | 2008 | 2256 | 0.040 |
Why?
|
Radiopharmaceuticals | 2 | 2007 | 2634 | 0.040 |
Why?
|
Transducers | 1 | 1980 | 240 | 0.040 |
Why?
|
Registries | 1 | 2015 | 8469 | 0.040 |
Why?
|
Quality Control | 1 | 2002 | 828 | 0.040 |
Why?
|
Heart Rate | 1 | 2011 | 4179 | 0.040 |
Why?
|
Chi-Square Distribution | 2 | 2011 | 3465 | 0.040 |
Why?
|
Aldosterone | 1 | 2004 | 868 | 0.040 |
Why?
|
Costs and Cost Analysis | 2 | 2003 | 1677 | 0.040 |
Why?
|
Coronary Angiography | 1 | 2011 | 4563 | 0.040 |
Why?
|
Duodenum | 1 | 2001 | 486 | 0.040 |
Why?
|
Gaucher Disease | 2 | 1989 | 110 | 0.040 |
Why?
|
Consensus | 2 | 2022 | 3113 | 0.040 |
Why?
|
Manganese | 2 | 1998 | 395 | 0.040 |
Why?
|
Deoxyglucose | 2 | 1997 | 333 | 0.040 |
Why?
|
Ferrosoferric Oxide | 2 | 1996 | 348 | 0.040 |
Why?
|
Breast Neoplasms | 1 | 2005 | 21025 | 0.040 |
Why?
|
Healthcare Disparities | 1 | 2013 | 3388 | 0.040 |
Why?
|
Pancreatic Pseudocyst | 1 | 1997 | 110 | 0.040 |
Why?
|
Education | 1 | 2020 | 534 | 0.040 |
Why?
|
Technology Assessment, Biomedical | 1 | 1999 | 306 | 0.040 |
Why?
|
Magnetite Nanoparticles | 2 | 1996 | 316 | 0.040 |
Why?
|
Dextrans | 2 | 1996 | 574 | 0.030 |
Why?
|
Intraoperative Care | 1 | 2000 | 768 | 0.030 |
Why?
|
Disease-Free Survival | 1 | 2007 | 6828 | 0.030 |
Why?
|
Body Surface Area | 1 | 2016 | 197 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 1 | 2007 | 6544 | 0.030 |
Why?
|
Bone Resorption | 2 | 1991 | 720 | 0.030 |
Why?
|
Pulmonary Veins | 1 | 2002 | 745 | 0.030 |
Why?
|
Cerebellum | 1 | 2003 | 1496 | 0.030 |
Why?
|
Pain | 3 | 2004 | 5066 | 0.030 |
Why?
|
Kidney Diseases, Cystic | 1 | 1997 | 183 | 0.030 |
Why?
|
Fluorine Radioisotopes | 2 | 1997 | 413 | 0.030 |
Why?
|
Cost-Benefit Analysis | 1 | 2008 | 5508 | 0.030 |
Why?
|
Adenoma, Liver Cell | 1 | 1995 | 32 | 0.030 |
Why?
|
Carcinoma, Hepatocellular | 2 | 2006 | 2299 | 0.030 |
Why?
|
Health Services Accessibility | 1 | 2013 | 5397 | 0.030 |
Why?
|
Blood Component Transfusion | 1 | 2016 | 141 | 0.030 |
Why?
|
Prospective Studies | 8 | 2011 | 54303 | 0.030 |
Why?
|
Pancreatic Diseases | 1 | 1997 | 343 | 0.030 |
Why?
|
Recurrence | 1 | 2007 | 8482 | 0.030 |
Why?
|
Travel | 1 | 2000 | 785 | 0.030 |
Why?
|
Pregnancy Outcome | 1 | 2005 | 2907 | 0.030 |
Why?
|
Prostatic Neoplasms | 1 | 2017 | 11345 | 0.030 |
Why?
|
Telecommunications | 1 | 1994 | 80 | 0.030 |
Why?
|
Dilatation, Pathologic | 1 | 1995 | 527 | 0.030 |
Why?
|
Postoperative Complications | 2 | 2008 | 15697 | 0.030 |
Why?
|
Cementation | 1 | 1993 | 92 | 0.030 |
Why?
|
Pelvic Neoplasms | 1 | 1995 | 248 | 0.030 |
Why?
|
Pancreatic Cyst | 1 | 1997 | 367 | 0.030 |
Why?
|
Foreign-Body Reaction | 1 | 1993 | 157 | 0.030 |
Why?
|
Acute Disease | 2 | 2003 | 7269 | 0.030 |
Why?
|
Vena Cava, Inferior | 1 | 1996 | 458 | 0.030 |
Why?
|
Tumor Burden | 1 | 2018 | 1895 | 0.030 |
Why?
|
Body Height | 2 | 2016 | 1570 | 0.030 |
Why?
|
Truth Disclosure | 1 | 2016 | 432 | 0.020 |
Why?
|
Adenocarcinoma | 2 | 2007 | 6315 | 0.020 |
Why?
|
Uterus | 1 | 1995 | 651 | 0.020 |
Why?
|
Surgical Procedures, Operative | 1 | 2003 | 1913 | 0.020 |
Why?
|
Neck Injuries | 1 | 2012 | 160 | 0.020 |
Why?
|
Cysts | 4 | 1997 | 683 | 0.020 |
Why?
|
Attitude of Health Personnel | 1 | 2024 | 3865 | 0.020 |
Why?
|
Cooking | 1 | 2012 | 311 | 0.020 |
Why?
|
Feasibility Studies | 2 | 2018 | 5201 | 0.020 |
Why?
|
Prognosis | 2 | 2004 | 29658 | 0.020 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2006 | 4024 | 0.020 |
Why?
|
Fiducial Markers | 1 | 2011 | 132 | 0.020 |
Why?
|
Osmolar Concentration | 1 | 2011 | 660 | 0.020 |
Why?
|
Graft Survival | 1 | 2000 | 3794 | 0.020 |
Why?
|
Four-Dimensional Computed Tomography | 1 | 2011 | 144 | 0.020 |
Why?
|
Abdominal Injuries | 1 | 2012 | 359 | 0.020 |
Why?
|
Nail-Patella Syndrome | 1 | 1989 | 12 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2003 | 3736 | 0.020 |
Why?
|
Osteoma, Osteoid | 1 | 1990 | 90 | 0.020 |
Why?
|
Spleen | 1 | 1995 | 2298 | 0.020 |
Why?
|
Parathyroidectomy | 1 | 2011 | 241 | 0.020 |
Why?
|
Methylene Blue | 1 | 2009 | 157 | 0.020 |
Why?
|
Injections, Intravenous | 1 | 2011 | 1385 | 0.020 |
Why?
|
Lung | 2 | 2005 | 9994 | 0.020 |
Why?
|
Prosthesis Failure | 1 | 1993 | 1206 | 0.020 |
Why?
|
Aorta | 1 | 1996 | 2039 | 0.020 |
Why?
|
Pressure | 2 | 1981 | 1156 | 0.020 |
Why?
|
Treatment Failure | 1 | 1993 | 2648 | 0.020 |
Why?
|
Infant | 2 | 2007 | 36060 | 0.020 |
Why?
|
Bone Marrow Diseases | 1 | 1989 | 232 | 0.020 |
Why?
|
Endometriosis | 1 | 1995 | 874 | 0.020 |
Why?
|
Hip Joint | 1 | 1993 | 1006 | 0.020 |
Why?
|
Thyroid Gland | 1 | 1993 | 1168 | 0.020 |
Why?
|
Anti-Bacterial Agents | 2 | 2008 | 7408 | 0.020 |
Why?
|
Child, Preschool | 2 | 2007 | 42063 | 0.020 |
Why?
|
Fibula | 1 | 1989 | 265 | 0.020 |
Why?
|
Spinal Puncture | 1 | 2008 | 281 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2011 | 1180 | 0.020 |
Why?
|
Endometrial Neoplasms | 1 | 1995 | 1357 | 0.020 |
Why?
|
Ankle Joint | 1 | 1990 | 435 | 0.020 |
Why?
|
Lymphatic Metastasis | 2 | 2010 | 2943 | 0.020 |
Why?
|
Chronic Disease | 1 | 2000 | 9287 | 0.020 |
Why?
|
Melanoma | 1 | 2004 | 5697 | 0.020 |
Why?
|
Elbow Joint | 1 | 1988 | 356 | 0.020 |
Why?
|
Ovarian Cysts | 1 | 2005 | 108 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2016 | 10827 | 0.010 |
Why?
|
Radionuclide Imaging | 1 | 2008 | 1975 | 0.010 |
Why?
|
ROC Curve | 3 | 1997 | 3568 | 0.010 |
Why?
|
Observation | 1 | 2005 | 312 | 0.010 |
Why?
|
Uterine Cervical Neoplasms | 1 | 1995 | 2003 | 0.010 |
Why?
|
Pancreatic Neoplasms | 2 | 1998 | 5351 | 0.010 |
Why?
|
Cranial Nerve Diseases | 1 | 2003 | 112 | 0.010 |
Why?
|
Databases, Factual | 1 | 2018 | 8035 | 0.010 |
Why?
|
Clinical Competence | 1 | 2018 | 4783 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2000 | 15840 | 0.010 |
Why?
|
Maternal Age | 1 | 2005 | 807 | 0.010 |
Why?
|
Lymph Nodes | 1 | 1993 | 3486 | 0.010 |
Why?
|
Double-Blind Method | 2 | 2011 | 12427 | 0.010 |
Why?
|
Abnormalities, Multiple | 1 | 1989 | 1415 | 0.010 |
Why?
|
Menopause | 1 | 1989 | 1640 | 0.010 |
Why?
|
Disease Progression | 2 | 2010 | 13502 | 0.010 |
Why?
|
Buttocks | 1 | 1981 | 111 | 0.010 |
Why?
|
Probability | 1 | 2005 | 2475 | 0.010 |
Why?
|
Mammography | 1 | 2010 | 2427 | 0.010 |
Why?
|
Osteoporosis | 1 | 1989 | 1600 | 0.010 |
Why?
|
Arteries | 1 | 2003 | 1126 | 0.010 |
Why?
|
Chelating Agents | 1 | 2000 | 384 | 0.010 |
Why?
|
Neoplasm Invasiveness | 1 | 2006 | 3618 | 0.010 |
Why?
|
Linear Models | 1 | 2008 | 5877 | 0.010 |
Why?
|
Intestinal Diseases | 1 | 2002 | 506 | 0.010 |
Why?
|
Bone Density | 1 | 1991 | 3534 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2011 | 4048 | 0.010 |
Why?
|
Cystadenocarcinoma, Mucinous | 1 | 1997 | 50 | 0.010 |
Why?
|
Electrocardiography | 1 | 2011 | 6414 | 0.010 |
Why?
|
Pain Measurement | 1 | 2007 | 3528 | 0.010 |
Why?
|
Cystadenoma, Serous | 1 | 1997 | 100 | 0.010 |
Why?
|
Gestational Age | 1 | 2005 | 3565 | 0.010 |
Why?
|
Radiology, Interventional | 1 | 2000 | 475 | 0.010 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2008 | 3340 | 0.010 |
Why?
|
Adrenal Cortex | 1 | 1995 | 134 | 0.010 |
Why?
|
Evaluation Studies as Topic | 1 | 1997 | 1628 | 0.010 |
Why?
|
Hepatoblastoma | 1 | 1995 | 88 | 0.010 |
Why?
|
Mucins | 1 | 1997 | 568 | 0.010 |
Why?
|
Fatty Liver | 1 | 2000 | 778 | 0.010 |
Why?
|
Vascular Diseases | 1 | 2002 | 1182 | 0.010 |
Why?
|
Logistic Models | 1 | 2008 | 13314 | 0.010 |
Why?
|
Brain | 1 | 1999 | 26951 | 0.010 |
Why?
|
Kidney Diseases | 1 | 2002 | 2093 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2005 | 11071 | 0.010 |
Why?
|
Survival Analysis | 1 | 2003 | 10182 | 0.010 |
Why?
|
Aging | 1 | 1989 | 8651 | 0.010 |
Why?
|
Thyroid Diseases | 1 | 1993 | 386 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 1999 | 2696 | 0.010 |
Why?
|
Osteoradionecrosis | 1 | 1989 | 51 | 0.010 |
Why?
|
Talus | 1 | 1990 | 85 | 0.010 |
Why?
|
Neck | 1 | 1993 | 731 | 0.000 |
Why?
|
Plasmacytoma | 1 | 1989 | 171 | 0.000 |
Why?
|
Calcaneus | 1 | 1990 | 142 | 0.000 |
Why?
|
Menarche | 1 | 1989 | 529 | 0.000 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 1995 | 3765 | 0.000 |
Why?
|
Neoplasm Metastasis | 1 | 1995 | 4902 | 0.000 |
Why?
|
Spinal Diseases | 1 | 1989 | 559 | 0.000 |
Why?
|
Colonic Neoplasms | 1 | 1995 | 2526 | 0.000 |
Why?
|
Absorptiometry, Photon | 1 | 1989 | 1736 | 0.000 |
Why?
|
Spinal Neoplasms | 1 | 1989 | 716 | 0.000 |
Why?
|
Reference Values | 1 | 1989 | 4925 | 0.000 |
Why?
|
Thyroid Neoplasms | 1 | 1993 | 2332 | 0.000 |
Why?
|
Regression Analysis | 1 | 1989 | 6360 | 0.000 |
Why?
|
Lumbar Vertebrae | 1 | 1989 | 1868 | 0.000 |
Why?
|
Medicare | 1 | 1995 | 6786 | 0.000 |
Why?
|
Infant, Newborn | 1 | 1994 | 26181 | 0.000 |
Why?
|
Cross-Sectional Studies | 1 | 1989 | 25942 | 0.000 |
Why?
|